During the past decade, LMC Scarborough conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LMC Scarborough" are "Diabetes Mellitus" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "LMC Scarborough" in a lesser frequency.

Most popular intervention types in "LMC Scarborough" are "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Basal insulin Basaglar/Lantus + gliclazide MR" (1 trials), "Basal insulin glargine and lixisenatide" (1 trials), "Diabetes self-management education (DSME) program" (1 trials) and "Metformin" (1 trials). Other intervention names were less common.

The vast majority of trials in "LMC Scarborough" are 2 trials for "All" genders.

Currently, there are NaN active trials in "LMC Scarborough". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in LMC Scarborough, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LMC Scarborough, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".